Dr. Imtiaz Malik is a board-certified hematologist and medical oncologist with Erlanger Hematology and Oncology, which is a collaborative, comprehensive cancer care partnership between Erlanger Health System and Vanderbilt-Ingram Cancer Center.
Dr. Malik attended King Edward Medical University in Pakistan. Following medical school, he completed an internal medicine residency at Jewish Hospital & Medical Center in Brooklyn, New York, and two fellowships – a hematology fellowship at Thomas Jefferson University Hospital in Philadelphia and a hematology-oncology fellowship at the University of California Irvine.
Dr. Malik was an assistant professor at the University of California Los Angeles from 1985 to 1987. In 1987, he returned to Pakistan to establish the oncology unit at Aga Khan University Hospital. While there, he became an associate professor of medicine and dean of the faculty of medical oncology at the College of Physicians and Surgeons, Pakistan. He later relocated to the US, where he continued to pursue academic appointments like professor of medicine at the University of Cincinnati and professor of medicine and director of research at Loma Linda University School of Medicine, where he also served as interim chief of oncology.
Dr. Malik has published over 70 research articles in peer-reviewed journals. He is credited with some of the earliest work on outpatient management of neutropenic febrile patients. His clinical interests include gastrointestinal oncology.